Skip to content

Nan Fung Group Holdings Ltd

Follow

13F filer, CIK 1782539, KAI TAK, Hong Kong

Nan Fung Group Holdings Ltd reported $111,726,254 across 27 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-13. Its ten largest share positions make up 79.75% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001012975-26-000144

Period
2025-12-31
Reported value
$112M
Holdings
27
Top 10 weight
79.75%
New
4
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
EVMNnew+1,441,032$24.7M
MPLTnew+971,253$17.1M
PCORnew+53,299$3.88M
HELPnew+460,000$3.76M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
JOBYexited-217,320-$3.51M
RKLBreduced-25,716-$1.79M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2025

Share positions as resolved from 13F-HR 0001012975-26-000144, largest first. % of portfolio is the value over $111,726,254, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
EVMNEVOMMUNE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,441,032 shares 1,441,032$24.7M22.08%newTimeline
MPLTMAPLIGHT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 971,253 shares 971,253$17.1M15.27%newTimeline
OCSOCULIS HOLDING AGQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 436,378 shares; 2024Q4: 436,378 shares; 2025Q1: 514,702 shares; 2025Q2: 514,702 shares; 2025Q3: 514,702 shares; 2025Q4: 514,702 shares 514,702$10.3M9.2%0Timeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 9,762 shares; 2024Q4: 11,122 shares; 2025Q1: 11,872 shares; 2025Q2: 11,872 shares; 2025Q3: 11,872 shares; 2025Q4: 11,872 shares 11,872$6.91M6.19%0Timeline
LBRXLB PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 300,000 shares; 2025Q4: 300,000 shares 300,000$6.68M5.98%0Timeline
INCYINCYTE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 74,022 shares; 2024Q4: 67,022 shares; 2025Q1: 59,022 shares; 2025Q2: 59,022 shares; 2025Q3: 59,022 shares; 2025Q4: 59,022 shares 59,022$5.83M5.22%0Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 49,120 shares; 2024Q4: 49,120 shares; 2025Q1: 49,120 shares; 2025Q2: 49,120 shares; 2025Q3: 49,120 shares; 2025Q4: 49,120 shares 49,120$5.26M4.71%0Timeline
ONCBEONE MEDICINES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 23,022 shares; 2024Q4: 19,997 shares; 2025Q1: 15,722 shares; 2025Q2: 15,722 shares; 2025Q3: 15,722 shares; 2025Q4: 15,722 shares 15,722$4.78M4.28%0Timeline
PCORPROCORE TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 53,299 shares 53,299$3.88M3.47%newTimeline
HELPCYBIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 460,000 shares 460,000$3.76M3.37%newTimeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 13,600 shares; 2024Q4: 13,600 shares; 2025Q1: 13,600 shares; 2025Q2: 13,600 shares; 2025Q3: 13,600 shares; 2025Q4: 13,600 shares 13,600$2.9M2.6%0Timeline
ACADACADIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 102,984 shares; 2024Q4: 102,984 shares; 2025Q1: 102,984 shares; 2025Q2: 102,984 shares; 2025Q3: 102,984 shares; 2025Q4: 102,984 shares 102,984$2.75M2.46%0Timeline
RXRXRECURSION PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 664,610 shares; 2025Q1: 664,610 shares; 2025Q2: 664,610 shares; 2025Q3: 595,287 shares; 2025Q4: 595,287 shares 595,287$2.43M2.18%0Timeline
LABSTANDARD BIOTOOLS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,883,179 shares; 2024Q4: 1,883,179 shares; 2025Q1: 1,883,179 shares; 2025Q2: 1,883,179 shares; 2025Q3: 1,883,179 shares; 2025Q4: 1,883,179 shares 1,883,179$2.41M2.16%0Timeline
KYMRKYMERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 10,875 shares; 2024Q4: 30,875 shares; 2025Q1: 30,875 shares; 2025Q2: 30,875 shares; 2025Q3: 30,875 shares; 2025Q4: 30,875 shares 30,875$2.4M2.15%0Timeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 430 shares; 2024Q4: 430 shares; 2025Q1: 2,800 shares; 2025Q2: 2,800 shares; 2025Q3: 2,800 shares; 2025Q4: 2,800 shares 2,800$2.35M2.11%0Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,300 shares; 2024Q4: 19,253 shares; 2025Q1: 19,253 shares; 2025Q2: 19,253 shares; 2025Q3: 19,253 shares; 2025Q4: 19,253 shares 19,253$1.53M1.37%0Timeline
ETHAISHARES ETHEREUM TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,549 shares; 2025Q4: 50,549 shares 50,549$1.13M1.01%0Timeline
HRMYHARMONY BIOSCIENCES HLDGS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 368,665 shares; 2024Q4: 368,665 shares; 2025Q1: 368,665 shares; 2025Q2: 368,665 shares; 2025Q3: 27,049 shares; 2025Q4: 27,049 shares 27,049$1.01M0.91%0Timeline
IBITISHARES BITCOIN TRUST ETFQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 15,968 shares; 2025Q4: 15,968 shares 15,968$793K0.71%0Timeline
RANIRANI THERAPEUTICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 493,584 shares; 2024Q4: 493,584 shares; 2025Q1: 493,584 shares; 2025Q2: 493,584 shares; 2025Q3: 493,584 shares; 2025Q4: 493,584 shares 493,584$666K0.6%0Timeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 287,846 shares; 2024Q4: 321,746 shares; 2025Q1: 414,246 shares; 2025Q2: 63,719 shares; 2025Q3: 63,719 shares; 2025Q4: 63,719 shares 63,719$619K0.55%0Timeline
TRDAENTRADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 49,082 shares; 2024Q4: 49,082 shares; 2025Q1: 49,082 shares; 2025Q2: 49,082 shares; 2025Q3: 49,082 shares; 2025Q4: 49,082 shares 49,082$505K0.45%0Timeline
BCYCBICYCLE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 31,585 shares; 2024Q4: 68,943 shares; 2025Q1: 68,943 shares; 2025Q2: 68,943 shares; 2025Q3: 68,943 shares; 2025Q4: 68,943 shares 68,943$488K0.44%0Timeline
BOLTBOLT BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 58,347 shares; 2025Q3: 58,347 shares; 2025Q4: 58,347 shares 58,347$319K0.29%0Timeline
RKLBROCKET LAB CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 29,540 shares; 2025Q4: 3,824 shares 3,824$267K0.24%-25,716Timeline
BSLKBOLT PROJS HLDGS INC COM NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 40,597 shares; 2025Q3: 40,597 shares; 2025Q4: 40,597 shares 40,597$32.4K0.03%0Timeline

Sold out in Q4 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
JOBYJOBY AVIATION INC217,320$3.51Mshares

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001012975-26-000144 base2026-02-13acceptance time not in the bulk data set